Electronic skin (e‐skin) integrating pressure sensors and strain sensors has shown great potential applications in smart robotics and healthcare monitoring for their flexibility and wearability. However, making the sensor low cost and highly durable for industrialization and commercialization is still a problem to be addressed. An embedded 3D printing technology is developed based on novel thermosetting printing ink which is prepared using the Ecoflex and carbon nanoparticles. The properties of the printing ink including printability and electrical conductivity are first studied and then optimized. By using this technology, a glove‐shaped e‐skin integrating both strain sensors and pressure sensors is fabricated, and the properties of the sensors are studied. Both types of sensors have excellent stability and reliability which are verified by multiple long‐term measurements (10 000 testing cycles). Specifically, the sensors possess a great shock resistance and high durability which are significant for application in real life. Furthermore, some applications for human activity monitoring and personal healthcare are demonstrated, including complex gesture recognition using 15 strain sensors, hardness sensing using pressure sensors coupled with strain sensors, and arterial pulse measurement using pressure sensors, which are promising for smart robotic sensing and wearable biomedical devices.

Tumor heterogeneity is prevalent in both treatment-naïve and end-stage metastatic castrationresistant prostate cancer (PCa), and may contribute to the broad range of clinical presentation, treatment response, and disease progression. To characterize molecular heterogeneity associated with de novo metastatic PCa, multiplatform single cell profiling was performed using high definition single cell analysis (HD-SCA). HD-SCA enabled morphoproteomic and morphogenomic profiling of single cells from touch preparations of tissue cores (prostate and bone marrow biopsies) as well as liquid samples (peripheral blood and bone marrow aspirate). Morphology, nuclear features, copy number alterations, and protein expression were analyzed. Tumor cells isolated from prostate tissue touch preparation (PTTP) and bone marrow touch preparation (BMTP) as well as metastatic tumor cells (MTCs) isolated from bone marrow aspirate were characterized by morphology and cytokeratin expression. Although peripheral blood was examined, circulating tumor cells were not definitively observed. Targeted proteomics of PTTP, BMTP, and MTCs revealed cell lineage and luminal prostate epithelial differentiation associated with PCa, including co-expression of EpCAM, PSA, and PSMA. Androgen receptor expression was highest in MTCs. Hallmark PCa copy number alterations, including PTEN and ETV6 deletions and NCOA2 amplification, were observed in cells within the primary tumor and bone

In this paper, we describe an automated microfluidic flow loop analyzer toward an in-situ phosphate measurement in natural waters. The system consists of a microfluidic chip and a setup for driving and detecting which form a microfluidic flow loop analyzer with one peristaltic micropump, seven microvalves, three inlets, one outlet and a loop channel which connects them together. The loop channel functions as a mixer, and the mixing process can be monitored continuously. Three reagents can be injected into the water sample at any time. The reagent consumption is 6 μL per sample for one measurement of the phosphate concentration, which would increase the in-situ usage time greatly because of the limited reagents. The analyzer is small, and its power consumption is low (343 mW), which increase the potential of the analyzer for monitoring phosphate in situ. The analyzer has been calibrated, and its performance has been quantified. Because of the continuous monitoring function of the microflow loop, we increase sample throughput to 10 samples per hour. The phosphate concentrations of the water samples have been measured using both normal method and rapid method we proposed. The results show there are no significant differences between our analyzer and reference procedures.

Bi-directional crosstalk between the tumor and the tumor microenvironment (TME) has been shown to increase the rate of tumor evolution and to play a key role in neoplastic progression, therapeutic resistance, and a patient’s overall survival. Here, we set out to use a comprehensive liquid-biopsy analysis to study cancer and specific TME cells in circulation and their association with disease status. Cytokeratin+, CD45- circulating rare cells (CRCs) from nine breast and four prostate cancer patients were characterized through morphometrics, single-cell copy number analysis, and targeted multiplexed proteomics to delineate cancer cell lineage from other rare cells originating in the TME. We show that we can detect epithelial circulating tumor cells (EPI.CTC), CTCs undergoing epithelial-to-mesenchymal transition (EMT.CTC) and circulating endothelial cells (CECs) using a universal rare event detection platform (HDSCA). Longitudinal analysis of an index patient finds that CTCs are present at the time of disease progression, while CECs are predominately present at the time of stable disease. In a small cohort of prostate and breast cancer patients, we find high inter-patient and temporal intra-patient variability in the expression of tissue specific markers such as ER, HER2, AR, PSA and PSMA and EpCAM. Our study stresses the importance of the multi-omic characterization of circulating rare cells in patients with breast and prostate carcinomas, specifically highlighting overlapping and cell type defining proteo-genomic characteristics of CTCs and CECs.